Viewing Study NCT05606159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-01-24 @ 10:19 PM
Study NCT ID: NCT05606159
Status: WITHDRAWN
Last Update Posted: 2024-11-22
First Post: 2022-08-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections
Sponsor: Novozymes A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clostridium Difficile Infection Recurrence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Probiotic View
None Gastrointestinal Microbiota View
None C. difficile View
None Dietary supplement View